Key Event: Change in Senior Management
Dr. Preet Kaur, Chief Scientific Officer and part of the Senior Management Personnel, has resigned from the company. The reason for her cessation is resignation to pursue a better career opportunity outside the organization.
Effective Date and Transition
Her cessation is effective from November 06, 2026. The handover process is stated to be complete as of this effective date. In her resignation letter (dated October 08, 2026), she requested November 06, 2026, to be considered her last working day, which aligns with the notice period.
Company's Response and Forward Plan
The company has placed on record its appreciation for her contributions. It is disclosed that the process of identifying a suitable replacement for the Chief Scientific Officer position is "substantially progressed." The details of the new appointment will be intimated to the stock exchanges in due course, in compliance with applicable laws.
Compliance and Submission Details
The disclosure was signed and submitted by Brijesh Kumar, Company Secretary and Compliance Officer, on November 06, 2026. The disclosure is also being made available on the company's website at https://investor.thyrocare.com/announcements/.
Financial and Operational Impact
The disclosure does not quantify any financial impact resulting from this management change. The operational impact is mitigated by the stated completion of the handover process and the advanced stage of finding a replacement.
#Tags: #Thyrocare #ManagementChange #SEBIDisclosure #RegulatoryCompliance #Neutral